Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: A review of 73 cases in Hong Kong

Hematological Oncology

Volumn 15, Issue 3, 1997, Pages 141-149

  Ma, S K ^a   Chan, G C F ^a   Ha, S Y ^a   Chiu, D C K ^a   Lau, Y L ^a   Chan, L C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Childhood ALL; Cytogenetics; Immunophenotype; Treatment outcome

Indexed keywords

METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL EXAMINATION; FEMALE; FEVER; HEPATOSPLENOMEGALY; HONG KONG; HUMAN; IMMUNOPHENOTYPING; INFANT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0031429293     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199708)15:3<141::AID-HON608>3.0.CO;2-5     Document Type: Article

References (23)

1. Pui, C. H., Crist, W. M. Treatment of childhood leukemias. Curr. Opin. Oncol. 1995, 7, 36-44.
2. Pui, C. H., Behm, F. G., Crist, W. M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993, 82, 343-362.
3. Pui, C. H., Crist, W. M., Look, A. T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990, 76, 1449-1463.
4. Pui, C. H. Childhood leukemias. N. Engl. J. Med. 1995, 332, 1618-1630.
5. Conter, V., Aricò, M., Valsecchi, M. G., et al. Associazione Italiana di Ematologia ed Oncologia Pediatrica. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. J. Clin. Oncol. 1995, 13, 2497-2502.
6. Reiter, A., Schrappe, M., Ludwig, W. D., et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994, 84, 3122-3133.
7. Schorin, M. A., Blattner, S., Gelber, R. D., et al. Treatment of childhood acute lymphoblastic leukemia: results of the Dana-Faber Cancer Institute Children Hospital acute lymphoblastic leukemia consortium protocol 85-01. J. Clin. Oncol. 1994, 12, 740-747.
8. Verman, A. J. P., Hählen, K., Kamps, W. A., et al. High cure rate with a moderately intensive treatment regimen in non-high risk childhood acute lymphoblastic leukemia: results of protocol ALL VI (1984-88) from the Dutch Childhood Leukemia Study Group. J. Clin. Oncol. 1996, 14, 911-918.
9. Schaison, G., Sommelet, D., Bancillon, A., et al. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87. Leukemia 1992, 6(Suppl. 2), 148-152.
10. Chessells, J. M., Bailey, C., Richards, S. M. for the Medical Research Council Working Party on Childhood Leukemia. Intensification of treatment and survival in all children with lymphoblastic leukemia: results of UK Medical Research Council UKALL X. Lancet 1995, 345, 143-148.
11. Rivera, G. K., Raimondi, S. C., Hancock, M. L., et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991, 337, 61-66.
12. Bennett, J. M., Catovsky, D., Daniel, M-T., et al. French-American-British (FAB) Co-operative Group: Proposals for the classification of acute leukemias. Br. J. Haematol. 1976, 33, 451-458.
13. Pinkel, D., Woo, S. Prevention and treatment of meningeal leukemia in children. Blood 1994, 84, 355-366.
14. Slaper-Cortenbach, I. C. M., Admiraal, L. G., Kerr, K. M., van Leeuwen, E. F., von dem Borne, A. E. G., Tetteroo, P. A. T. Flow cytometric detection of terminal transferase and other intracellular antigens in combination of membrane antigens in acute lymphoblastic leukemia. Blood 1988, 72, 1639-1646.
15. First MIC Co-operative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 1986, 23, 189-197.
16. Chan, L. C., Ha, S. Y., Ching, L. M., et al. Cytogenetics and immunophenotypes of childhood acute lymphoblastic leukemias in Hong Kong. Cancer Genet. Cytogenet. 1994, 76, 118-124.
17. Mitelman, F. (ed. ISCN) (1991). Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1991.
18. Eden, O. B., Lilleyman, J. S., Richards, S., Shaw, M. P., Peto, J. Results of the Medical Research Council Childhood Leukemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukemia in Childhood). Br. J. Haematol. 1991, 78, 187-196.
19. Kaplan, E. L., Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53, 457-481.
20. Breslow, N. Comparison of survival curves. In: Buyse, M., Staquet, M., Sylvester, R., eds. Cancer Clinical Trials: Methods and Practice. Oxford: Oxford University, 1984: 381-406.
21. Chessells, J. M. Treatment of childhood ALL. In: Brenner, M. K., Hoffbrand, A. V., eds. Recent Advances in Hematology 8. Edinburgh: Churchill Livingstone, 1996: 45-63.
22. Smith, M., Arthur, D., Camitta, B., et al. Uniform approach to risk-classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 1995, 14, 18-24.
23. Pui, C. H. Acute leukemia in children. Curr. Opin. Hematol. 1996, 3, 249-258.